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Spondylo-megaepiphyseal-metaphyseal dysplasia (SMMD) is a rare skeletal dysplasia with only a few cases reported in the literature.
Affected individuals have a disproportionate short stature with a short and stiff neck and trunk. The limbs appear relatively long and
may show ﬂexion contractures of the distal joints. The most remarkable radiographic features are the delayed and impaired ossiﬁcation
of the vertebral bodies as well as the presence of large epiphyseal ossiﬁcation centers and wide growth plates in the long tubular bones.
Numerous pseudoepiphyses of the short tubular bones in hands and feet are another remarkable feature of the disorder. Genome wide
homozygosity mapping followed by a candidate gene approach resulted in the elucidation of the genetic cause in three new consanguin-
eous families with SMMD. Each proband was homozygous for a different inactivating mutation in NKX3-2, a homeobox-containing
gene located on chromosome 4p15.33. Striking similarities were found when comparing the vertebral ossiﬁcation defects in SMMD
patients with those observed in theNkx3-2 null mice. Distinguishing features were the asplenia found in themutant mice and the radio-
graphic abnormalities in the limbs only observed in SMMD patients. The absence of the latter anomalies in the murine model may be
due to the perinatal death of the affected animals. This study illustrates that NKX3-2 plays an important role in endochondral ossiﬁca-
tion of both the axial and appendicular skeleton in humans. In addition, it deﬁnes SMMD as yet another skeletal dysplasia with auto-
somal-recessive inheritance and a distinct phenotype.The formation of the axial skeleton in vertebrate organ-
isms starts with the generation of paired somites along
both sides of the neural tube and the notochord, followed
by the compartimentation of these somites into dermato-
myotome and sclerotome.1,2 Sclerotomal cells subse-
quently differentiate into chondroblasts to form vertebral
templates. These cartilaginous models further grow and
undergo endochondral ossiﬁcation, resulting in mature
vertebral bodies.3 Defects at each step of this develop-
mental process may result in different types of vertebral
anomalies. Defects at the initial step of somitogenesis
will result in abnormal formation (patterning) of the
vertebral bodies, whereas defects later on will result in
abnormal growth and ossiﬁcation of otherwise well-seg-
mented vertebrae.
The study of human skeletal disorders that affect the
vertebral column can give us more insights into the genes
that regulate axial skeletogenesis. For example, the identi-
ﬁcation of DLL3 (MIM 602768) mutations in patients with
spondylocostal dysostosis type 1 (SCDO1 [MIM 277300])
has highlighted the crucial role of notch signaling in
human somitogenesis.4 Individuals affected with SCDO1
have multiple vertebral segmentation defects throughout
the entire spine. The important role of type 2 collagen,
the major ﬁbrillar constituent of cartilage matrix, in endo-
chondral ossiﬁcation is exempliﬁed by the lack of vertebral
ossiﬁcation in fetuses with severe achondrogenesis type 2(ACG2 [MIM 200610]). The latter condition is caused by
COL2A1 (MIM 120140) missense mutations that substitute
a glycine residue within the triple helical domain of the
type 2 procollagen chain.5
This study reports the mapping of the causal gene for
a rare bone dysplasia affecting vertebral ossiﬁcation and
delineated for the ﬁrst time in 1985 by Silverman and
Reiley.6 These authors reported eight patients with a condi-
tion resembling severe cleidocranial dysplasia (CCD [MIM
119600]) and suggested the term spondylo-megaepiphy-
seal-metaphyseal dysplasia (SMMD) to distinguish this
new entity from CCD. Recurrence in siblings and consan-
guinity in the parents suggested an autosomal-recessive
mode of inheritance. It took almost 20 years before
another patient was reported.7 With only nine cases being
described up to now, SMMD remains a very rare condition,
not listed in OMIMnor incorporated in the 2006 version of
the Nosology and Classiﬁcation of Genetic Skeletal Disor-
ders.8 Nevertheless, the disorder has a distinct clinical
and radiographic phenotype. Affected individuals have
a short stature with a short trunk and relatively long limbs.
The head is often large with a broad face and widely spaced
eyes. Mobility in the neck and back is usually limited.With
the exception of one boy, all reported patients have
a normal intelligence. The most striking features on radio-
graphs are the little or no ossiﬁcation of the vertebral
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centers that are separated by wide cartilage zones from the
adjacent and irregular metaphyses. The defective ossiﬁca-
tion in the axial skeleton mostly involves the vertebral
bodies with preservation of the pedicles and neural arches
that are often unfused posteriorly. Pelvic abnormalities
include delayed ossiﬁcation of the pubic bones, widened
triradiate cartilages, and coxa vara with large capital
femoral epiphyses. The ribs are usually short and appear
to originate remotely from the vertebral column. Multiple
pseudoepiphyses in hands and feet are often observed and
may suggest a disturbance in the determination of prox-
imal-distal polarity in tubular bones.
We ascertained three previously unreported families
with SMMD. The ﬁrst family comprised two affected
siblings, both children of Turkish consanguineous parents.
The proband (patient IV.3) was a 20-year-old man who pre-
sented at birth with a short trunk and inwhom initially the
diagnosis of hypochondrogenesis was made because of
defective ossiﬁcation of the vertebral column. At the age
of 13 years, he received a laminectomy and a ventriculoper-
itoneal shunting because of progressive pyramidal signs in
the lower limbs caused by cervical spine stenosis and
hydrocephalus. His adult height was 130 cm (span 160 cm)
and head circumference 53.4 cm (2.5 SD). Physical exam-
ination revealed a short neck, pectus carinatum, severe
kyphoscoliosis, and relatively long limbs. Some of his
ﬁngers were disproportionally long and showed ﬂexion
contractures. Both thumbs were proximally implanted
and subluxated (Figures 1A and 1B). He needed a wheel-
chair for transport over long distances and required
breathing support at night. The diagnosis in his sister
Figure 1. Clinical Features of the Individ-
uals Affected with SMMD
(A and B) Proband IV.3 is wearing a neck
brace because of cervical instability. His
limbs are relatively long. Note the ﬂat
feet with long halluces. Both thumbs are
proximally implanted and subluxated at
the metacarpophalangeal joint. Complete
extension of all ﬁngers is not possible.
Note the very long middle ﬁnger of the
right hand.
(C) Proband IV.8 also has a short trunk and
relatively long halluces.
(D and E) The proband of the third family
has a kyphoscoliosis with shortening of
the trunk. Her feet are remarkable with
very long halluces in comparison to the
other toes.
was made at 18 weeks’ gestation on
the basis of underossiﬁcation of the
spine on ultrasound. The pregnancy
was terminated at 19 weeks.
The second family comprised two
affected siblings born to ﬁrst-cousin
parents of Turkish origin. The pro-
band (patient IV.8) was an 18-year-
old girl who was referred because of gait difﬁculties and
back pain. She was unable to walk long distances without
assistance. She was operated in childhood for bilateral
hip dislocation and right clubfoot. She was short statured
(height 129 cm) with a short neck and trunk. She had
thoracic kyphoscoliosis and experienced limited mobility
in the left shoulder. The small ﬁnger joints and elbows
were hyperextensible (Figure 1C). Her affected brother
died at the age of 3 months.
In the third consanguineous family of Moroccan origin,
two female siblings were affected. The oldest girl was born
with a low birth weight. She had a delayed motor develop-
ment but was of normal intelligence. Her height at the
age of 11 years was 105 cm (6.3 SD). Clinical evaluation
revealed a short trunk with short neck, scoliosis, and very
long halluces (Figures 1D and 1E). The younger sister
presented at birth with contractures of ﬁngers and right
wrist. Her length at 18months was 62 cm (7.5 SD). Radio-
graphs in all affected individuals were characteristic for
SMMD (Figure 2).
To unravel the genetic defect of SMMD, we performed
a whole-genome homozygosity mapping analysis in fami-
lies 1 and 2 (family 3 was not available at the start of the
study) (Figure 3). Informed consent was obtained for all
individuals included in this study. The study was approved
by the local ethical committee and is in accordance with
institutional and national standards on human research.
DNA of both probands was analyzed by means of a high-
density SNP screening with GeneChip Human 250K Nsp
arrays. We processed all genotypic information in a Micro-
soft Excel spreadsheet by ﬁrst sorting genetic markers byThe American Journal of Human Genetics 85, 916–922, December 11, 2009 917
Figure 2. Radiographic Abnormalities in the Individuals
Affected with SMMD
(A–C) Radiographs taken in proband IV.3 at the age of 10 months.
(A) The vertebral bodies are incompletely ossiﬁed and show
sagittal clefts. The pedicles are well ossiﬁed in the lower thoracic
and upper lumbar region. The ribs originate remotely from the
vertebral column.
(B) The pelvis is abnormal with short iliac wings, widened trira-
diate cartilages, and absent ossiﬁcation of the pubic bones.
Remarkable are the round femoral epiphyses separated by a broad
cartilage zone (growth plate) from their metaphyses.
(C) The knee and ankle epiphyses are also rounded and ballooned
and located remotely from the metaphyses. The tubular bones are
poorly modeled.
(D) Babygram of the affected sib of proband IV.3 taken at 19 weeks’
gestational age showing complete absence of vertebral ossiﬁ-
cation.
(E–G) Radiographs taken in the third proband at the age of
11 years.
(E) Defective ossiﬁcation of the cervical spine that mostly involves
the vertebral bodies with preservation of the pedicles and neural
arches.
(F) The iliac wings are tall and narrow. The pubic bones are not yet
ossiﬁed. Severe coxa vara is present withmetaphyseal irregularities
at the acetabular roofs and femoral necks that show ossiﬁcation
defects.
(G) Multiple pseudoepiphyses are present, mostly visible in the
metacarpals and proximal phalanges. All epiphyses are large for
age. Metaphyseal irregularities are also present and in some
instances resemble enchondromata, especially those at the distal
radius, distal part of second and third metacarpals, and proximal
part of the ﬁrst to fourth proximal phalanges. The second meta-
carpal is very tall.918 The American Journal of Human Genetics 85, 916–922, Decembchromosomal position followed by identifying all homo-
zygous regions, taking into account a small percentage of
SNP miscalls. To eliminate regions with homozygosity
by state, we used an arbitrary cutoff of 500 consecutive
homozygous SNPs. After this selection, 12 regions with
homozygosity by descent were retained in each patient.
Assuming the same gene to be implicated in both families,
a selection for regions with homozygosity in both patients
was made. This resulted in two candidate intervals on
chromosome 4 located between 11.2 Mb to 14.5 Mb and
between 21.0 Mb to 37.2 Mb, respectively (Figure 4A).
Analysis of 13 microsatellite markers across both regions
in all available family members suggested linkage to the
smaller interval (Figure 3). Because of the low inherent
power of the investigated families, no signiﬁcant LOD
score (Z ¼ 1.98 for theta ¼ 0) could be obtained. The
high resolution of the performed analysis did however
provide sufﬁcient conﬁdence to delineate a ﬁnal region
of interest between SNP rs11722485 and microsatellite
marker D4S1602. This region contained three known
genes (RAB28 [MIM 612994], NKX3-2 [MIM 602183], and
FAM44A), a pseudogene, and some hypothetical genes
(Figure 4B).
NKX3-2 was selected as a good candidate gene because
its murine homolog was demonstrated to be essential for
proper axial skeletogenesis.9,10 Sequence analysis of the
NKX3-2 gene revealed two different homozygous muta-
tions in the two SMMD probands. Both mutations
(c.336_337 delGGinsT in patient IV.8 and c.337 dupG in
patient IV.3) result in a frameshift with a premature stop
codon in the ﬁrst exon (Figure 4D). Sequence analysis of
the NKX3-2 gene in the two affected sisters of family 3
revealed homozygosity for a third inactivating mutation
in the ﬁrst exon (c.104_110 delCGCCCGG, data not
shown). These nucleotide changes were not found in
a set of 210 control alleles, demonstrating that they are
not common in the general population (allele frequency
below 1%, 80% power11).
To investigate the effect of NKX3-2 mutations in these
patients, we performed an expression assay with real-
time quantitative PCR (qPCR). We cultured skin ﬁbroblasts
of patient IV.8 and treated half of the cultures with cyclo-
heximide (CHX) to block nonsense -mediated decay.
Comparison of NKX3-2 expression in both culture types
revealed increased levels of NKX3-2 after CHX treatment
(Figure 5A), demonstrating the presence of partial (~50%)
nonsense-mediated decay of the mutant transcripts. This
effect of CHX treatment was not observed in the normal
skin ﬁbroblasts. In addition, higher levels of NKX3-2
(H and I) Radiographs taken in proband IV.8 at the age of 18 years.
(H) Only few hand abnormalities are visible at this age. Pseudoe-
piphyses are still present in the thumb. Not all growth plates are
closed. Note the tall ﬁrst metacarpal and proximal phalanx and
still enlarged distal epiphyses of radius and ulna.
(I) The pelvis shows hypoplastic iliac wings, severe coxa vara
with dysplastic femoral heads, and incomplete ossiﬁcation of the
pubic rami.er 11, 2009
Figure 3. SMMD Pedigrees with Genotypes
Pedigrees of two consanguineous families, each containing one SMMD patient (ﬁlled icon) available for analysis. Black bars indicate the
haplotype that segregates with SMMD. The candidate region (framed area) is deﬁned by recombinations between markers D4S1582 and
D4S2906 in patient IV.3 and between D4S2984 and D4S1602 in individual IV.9.transcripts were observed in the skin ﬁbroblasts of patient
IV.8 compared to controls (Figure 5B). The upregulation of
mutant NKX3-2mRNAmay indicate a disturbed autoregu-
latory loop. The truncated NKX3-2 protein that lacks
the homeodomain (encoded by exon 2) may impair the
regulatory feedback of its own transcriptional activation.
Performing gain- and loss-of-function experiments in pre-somitic mesoderm explants from chicken embryos, Zeng
et al. have shown evidence for a positive regulatory loop
between Nkx3-2 and Sox9 (MIM 608160), which is impor-
tant for somitic chondrogenesis.12
The NKX3-2 (BAPX1) gene is located on chromosome
band 4p15.33 and codes for a homeobox-containing
protein of 333 amino acids (Figure 4E).10,13 It belongs toFigure 4. From Genome to Mutation
The top shows an ideogram of chromosome 4 for
patients IV.3 (top) and IV.8 (bottom) with homozy-
gous regions in dark gray. Horizontal bars below
the chromosomes indicate overlapping homozygous
regions. Shown underneath is a zoom in on the
linkage interval between SNP rs11722485 and
microsatellite D4S1602. Genes, pseudogenes, and
hypothetical genes are indicated below the chromo-
somal interval. NKX3-2 is located at the minus
strand of chromosome 4. Below that is a zoom in
on the genetic structure of the NKX3-2 gene with
two exons. Light-gray bars represent untranslated
regions; dark-gray bars indicate coding sequences.
Underneath that is the sequence of the NKX3-2
gene for a normal control (top), patient IV.3 (middle)
and patient IV.8 (bottom). The bottom shows
a NKX3-2 protein with indication of the homeobox
domain and the positions (V) at which SMMDmuta-
tions have been found: p.Ala35fs and p.Ala113fs
(twice).
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Figure 5. NKX3-2 Expression in Human Tissues
NKX3-2 expression analysis was performed with the qPCR assay with RTprimerDB ID #8115, a combination of expressed ALU repeats
(Alu Sq and Alu Sx) (Witt et al., unpublished data) and traditional reference genes (HPRT1 and YWHAZ) for normalization (geNorm30 M
stability measure < 0.5) and the qbasePLUS software for data analysis. Error bars represent the propagated standard error on repeated
measures
(A) Relative change in NKX3-2 expression after cycloheximide (CHX) treatment. No effect of CHX treatment can be seen in normal skin
ﬁbroblasts (þ25% and 18%), whereas in ﬁbroblasts of patient IV.8, CHX treatment leads to a doubling in NKX3-2 expression. These
results indicate a partial (~54%) nonsense mediated decay.
(B) Despite the partial NMD, patient ﬁbroblasts show a 10- to 40-fold higher NKX3-2 expression than similar cultures from normal
controls.
(C) Cross-tissue comparison of NKX3-2 expression. The highest levels of NKX3-2 expression were found in cartilage, bone (osteosar-
coma) and gut (small intestine and colon), whereas moderate expression was observed in trachea and brain. Normal skin ﬁbroblasts
only showed low levels of the NKX3-2 gene. NKX3-2 expression was also close to the detection limit for lung, breast, and kidney
(one out of four PCR replicates failed to amplify) and was undetectable in adrenal gland, heart, bone marrow, and liver. Details on
the samples used for NKX3-2 expression proﬁling are listed in Table S1 available online.the NK-2 family of homeobox-containing genes, which
is the second-most-abundant super class of homeobox
genes after the HOX class. This gene family has previously
been implicated in other human disorders such as congen-
ital anomalies of the heart (NKX2-6 [MIM 611770] and
NKX2-5 [MIM 600584]) (MIM 217095,14187500,15 and
10890016), cancer (NKX2-1 [MIM 600635 and 21198017]),
developmental anomalies of the eye (NKX5-3 [MIM
142992 and 61210918]) and in forms of choreoathetosis
and hypothyroidism (NKX2-1 and NKX2-5) [MIM
610978,19 118700,20 and 22525021].
In Drosophila, the homolog Bagpipe is required for the
speciﬁcation of the visceral mesoderm during midgut
musculature formation.22 In vertebrates, its expression in
essentially all cartilaginous condensations that undergo
endochondral bone formation suggests an additional role
in skeletogenesis. Mouse Nkx3-2 expression is detected
initially at embryonic day (E) 8.5 in the splanchnic meso-
derm adjacent to the prospective gut endoderm and in the
sclerotomal portion of the somites. At E10.5, Nkx3-2 is
detected in limb mesenchyme and the ﬁrst branchial
arch that becomes restricted to the precursor of Meckel’s
cartilage.10 In human embryos at day 52 (mouse equiva-
lent E13.5), NKX3-2 expression is visible in the gut meso-
derm, in the sclerotome, and in the cartilaginous templates
of developing bones in the limbs. With RNA in situ hybrid-
ization, no expression is observed in the nervous system
and neurogenic neural crest-derived tissues.10 Because of
its expression in the early stage of chondrogenesis, Nkx3-2
is regarded as one of the earliest markers for the sclerotome
lineage that forms the axial skeleton. We analyzed the
expression of NKX3-2 across different adult cell types920 The American Journal of Human Genetics 85, 916–922, Decemb(Figure 5C). The highest expression was observed in chon-
drocytes and gut. In contrast to the previous report, we
were able to demonstrate NKX3-2 expression in the
nervous system (brain) with the more sensitive and quan-
titative qPCR assay.
Nkx3-2/ mice are affected by a perinatally lethal skel-
etal dysplasia. They are asplenic and have a shorter verte-
bral column with a normal number of vertebrae that
appear more compact. The migration of mesenchymal
cells toward the notochord is normal, but the subsequent
organization and differentiation of these cells (after
E12.5) to form the cartilaginous templates of the preverte-
brae is impaired.23,24 The vertebral bodies are not fused in
the midline and may lack ossiﬁcation centers, mainly in
the cervical region. The neural arches are less affected
and only reduced in size.9,23,24 Despite the expression of
Nkx3-2 in all cartilaginous condensations of the devel-
oping limb, no defects are observed in the appendicular
skeleton at any prenatal stage.
Several studies have indicated essential roles for Shh,
Bmps, and the transcription factors Pax1, Pax9, Nkx3-2,
Runx2, and Sox9 in the signaling cascade regulating
axial chondrogenesis (MIM 600725, 167411, 167416,
and 600211). Shh signaling from the notochord and ﬂoor
plate induces a competence in somitic cells for subsequent
BMP2 (MIM 112261) signals to activate chondrogene-
sis.25,26 This chondrogenic competence is established by
the induction of both Sox9 and Nkx3-2 and a positive
regulatory loop between these two transcription factors.12
This results in the expression of early cartilage differentia-
tion markers such as aggrecan, collagen type II, and
epiphycan. Subsequently, and by inﬂuence of Sox9 ander 11, 2009
Nkx3-2, Runx2 will promote cartilage maturation and
endochondral ossiﬁcation by inducing Ihh and collagen
type X expression in (pre)hypertrophic chondrocytes.27
The stimulation of Nkx3-2 expression by Shh is, at least
in part, mediated by the transcription factors Pax1 and
Pax9.28 Forced expression of Nkx3-2 in presomitic meso-
derm is also found to be sufﬁcient to induce chondrogen-
esis in the presence of BMP signals.12
Studies in chick embryo limb buds have shown that
Nkx3-2 is initially expressed in all cartilaginous cells in
the limb bud soon after mesenchymal condensation but
as chondrocyte maturation begins, expression becomes
restricted to the immature proliferative chondrocytes.
The Nkx3-2 expression declines in the prehypertrophic
cells expressing Ihh and is at trace levels in mature hyper-
trophic chondrocytes expressing collagen type X. In addi-
tion, overexpression of Nkx3-2 inhibits chondrocyte
maturation.29 Taken together, these experiments indicate
that Nkx3-2 plays an important role in early somitic chon-
drogenesis and control of chondrocyte maturation during
limb development.
Our ﬁndings that homozygous inactivating mutations
in the NKX3-2 gene result in SMMD are largely in agree-
ment with the phenotype observed in the Nkx3-2
knockout mice. Defective ossiﬁcation of the anterior parts
of the vertebral bodies is present in both the Nkx3-2 null
mice and individuals with SMMD. On the other hand,
there are also differences between the human SMMD and
the murine Nkx3-2/ phenotypes. Skeletal defects in the
appendicular skeleton are found in patients with SMMD
but have not been reported in the mutant mice. This
discrepancy may be explained by the perinatal death of
Nkx3-2/ mice, before defects in the appendicular skel-
eton become apparent. In patients with SMMD, the radio-
graphic abnormalities in the limbs (large epiphyses, wide
metaphyses) only become visible after birth with the
appearance of the secondary ossiﬁcation centers. Second,
Nkx3-2/ mice have asplenia, a feature that has not
been reported in patients with SMMD. Ultrasonographic
evaluation of the abdomen in patient IV.3 revealed the
presence of a normal spleen.
In summary, our ﬁndings deﬁne SMMD as a distinct
entity within the group of rare skeletal dysplasias. The
identiﬁcation of homozygous inactivating mutations in
NKX3-2 supports the autosomal-recessive inheritance of
this condition and underscores the crucial role of this
homeobox-containing protein in ossiﬁcation of the
human vertebral column. The presence of mega- and pseu-
doepiphyses with wide growth plates in tubular bones of
SMMD patients conﬁrms the more generalized role of
NKX3-2 in endochondral ossiﬁcation of both the axial
and appendicular skeletal elements.
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